Last reviewed · How we verify

NCT03419091

LithoVue Single Use Disposable Ureteroscope

Status unknown NA Last updated 17 May 2022
What this trial tests

NA trial testing single-use flexible digital ureteroscope in Kidney Stone in 40 participants. Status unknown.

Timeline
1 December 2017
Primary endpoint
30 December 2023
30 December 2023

Quick facts

Lead sponsorUniversity of British Columbia
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 December 2017
Primary completion30 December 2023
Estimated completion30 December 2023
Sites2 locations across Canada, United States

Drugs / interventions tested

Conditions studied

Sponsor

University of British Columbia

Who can join

19 and older, any sex, with Kidney Stone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Most flexible ureteroscopes that are used to treat kidney stones have been reusable. Recently, advances in technology have resulted in single-use (disposable) ureteroscopes to become available. The investigators are interested in determining if the performance of the two types of scopes are equivalent. This will help guide institutions in the future to purchase the best scopes for their patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Kidney Stone

Currently open trials in the same condition.

Other University of British Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03419091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing